With FTC Nod, Stryker is Set to Close Wright Medical Deal

Stryker will divest its finger joint implants and STAR total ankle replacements to DJO to satisfy FTC requirements.

Omar Ford

November 4, 2020

1 Min Read
Sundry Photography-stock.adobe.com

Stryker is set to close on its deal to acquire Wright Medical Group for $4 billion on Nov. 10. The Kalamazoo, MI announced the closing date after the deal was greenlit by the U.S. Federal Trade Commission.

Stryker said FTC voted to approve the transaction Tuesday and the UK Competition and Markets Authority approved the transaction earlier today.

In order to get FTC’s blessing for the deal, both Stryker to divest all assets related to finger joint implants and STAR total ankle replacements. The companies have agreed to sell these assets to Carlsbad, CA-based DJO Global.

“We are pleased to receive the necessary regulatory approvals for the proposed acquisition of Wright Medical and to be moving ahead with the offer to the company’s shareholders,” said Kevin Lobo, Chairman and CEO, Stryker. “Wright Medical has built a successful business, and together we look forward to working with customers to continue delivering solutions that improve patient outcomes.”

Stryker first announced its bid to acquire Wright in Nov. of 2019. It is one of the largest holdover M&A deals from 2019 that had to clear regulatory hurdles.

Google’s plan to acquire Fitbit for $2.1 billion was also announced in Nov. of 2019 and like Stryker faced antitrust issues. The deal was put on hold because EU antitrust regulators offered concerns about the amount of data Google would have access to.

In September, EU regulators extended the antitrust investigation to Dec. 23. However, in October, EU regulators extended the time to Jan. 8, 2021 to make a decision.


About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].


Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like